Browse the evidence

Activation of SIRT1 (via fasting or chemical activators like SRT1720/SRT2183) directly deacetylates SREBP transcription factors, leading to their ubiquitination, decreased protein stability, and rapid degradation, thereby inhibiting lipid and cholesterol synthesis.

Fasting or using SIRT1-activating compounds (like resveratrol or specific activators studied in the paper) can inhibit the production of fats and cholesterol by directly targeting the SREBP proteins responsible for fat synthesis. This happens through a process where SIRT1 removes acetyl groups from SREBP, marking it for destruction, thereby reducing lipid storage.

In utero exposure to undernutrition (famine) increases susceptibility to increased adiposity and disrupted glucose homeostasis in female offspring, whereas male offspring are more susceptible to neurological damage and decreased brain volume.

If you are pregnant or planning pregnancy, be aware that your baby's sex influences how early nutritional stress (like famine or severe restriction) affects them. Female fetuses are more likely to develop metabolic issues (obesity/diabetes risk) if exposed to undernutrition, while male fetuses are more vulnerable to neurological damage. This suggests that optimal maternal nutrition is critical for both, but the specific risks differ by sex.

In utero exposure to overnutrition (maternal obesity/high sugar) increases susceptibility to increased adiposity and disrupted glucose homeostasis in female offspring, whereas male offspring are more susceptible to changes in adiposity and body weight in some models, or hypothalamic inflammation.

Maternal obesity and high-sugar diets during pregnancy program offspring for metabolic disease differently based on sex. Female offspring are particularly at risk for glucose homeostasis disruption and adiposity. This underscores the importance of managing maternal metabolic health before and during pregnancy, with awareness that the risks manifest differently in boys and girls.

Administration of recombinant GDF15 reduces body weight and improves insulin sensitivity in obese models by increasing energy expenditure, lipid mobilization, and fatty acid oxidation in liver, muscle, and adipose tissue.

This research identifies GDF15 as a potent signal that triggers fat burning and energy use. While not a current supplement, it highlights that improving mitochondrial health in muscle may naturally boost this hormone, aiding weight management.

Regular consumption of low to moderate amounts of alcohol (1-99 g/day) improves insulin sensitivity, evidenced by significantly lower fasting and post-glucose insulin concentrations and reduced insulin resistance compared to abstainers.

If you drink alcohol moderately (up to ~3-4 standard drinks per day), it may help your body handle insulin better than if you abstained completely. However, this does not mean you should start drinking for health reasons, as heavy drinking has severe negative health consequences. Focus on maintaining a healthy weight and staying active, as these factors have a larger impact on insulin sensitivity than alcohol.

The energy homeostasis system is inherently biased toward weight gain because catabolic pathways are tonically active in the basal state while anabolic pathways are suppressed, making the physiological response to weight loss (activation of anabolic pathways) more vigorous than the response to weight gain (further stimulation of already-active catabolic pathways).

Understand that your body is biologically wired to defend against weight loss more aggressively than it defends against weight gain. This is not a moral failing but a physiological reality: when you lose weight, your brain actively works to restore fat stores by increasing hunger and decreasing energy expenditure. Sustainable management likely requires strategies that account for this vigorous counter-response, such as maintaining catabolic pathway activation (e.g., through specific pharmacological targets or lifestyle habits) rather than relying solely on willpower to suppress anabolic signals.

In obese and diabetic rodent models, circulating resistin levels are elevated and positively correlated with insulin, glucose, and lipids, despite suppressed resistin mRNA expression in adipose tissue, indicating that nutritional regulation of resistin is mediated by insulin and glucose.

In obese individuals, high circulating resistin is linked to higher insulin and glucose levels, even if fat tissue gene expression is low. This suggests that managing insulin and glucose levels through diet and lifestyle may help regulate resistin, rather than focusing solely on fat mass reduction.

Leptin treatment reduces serum resistin and resistin mRNA expression in obese mice, an effect that is independent of weight loss or food intake, suggesting leptin directly regulates resistin to improve insulin sensitivity.

In obese individuals, hormonal signals like leptin may play a key role in regulating resistin levels, independent of weight loss. This suggests that improving leptin sensitivity through lifestyle changes might help normalize resistin levels.

Oral melatonin supplements have poor absolute bioavailability (approximately 15%) due to poor absorption and first-pass metabolism, whereas intravenous administration shows similar half-life but higher immediate serum peaks.

If using melatonin supplements, be aware that oral bioavailability is low (~15%). This means a significant portion is lost to metabolism. Sublingual or liquid forms may have different profiles, but standard tablets require careful dosing. Food sources provide a slower, sustained release with antioxidant benefits.

Reduced glucose flux into adipose tissue (due to GLUT4 downregulation or knockout) triggers the secretion of Retinol-Binding Protein 4 (RBP4), which acts as a signaling molecule to induce systemic insulin resistance in muscle and liver.

In states of insulin resistance, fat cells may stop taking up glucose efficiently and instead release a protein called RBP4 that tells your muscles and liver to resist insulin. This is a biological signal, not just a passive storage issue. Managing this involves improving overall metabolic flexibility, though the paper highlights this as a pathologic mechanism in diabetes rather than a direct lifestyle intervention protocol.

Muscle-specific knockout of GLUT4 causes secondary insulin resistance in liver and adipose tissue, demonstrating that muscle glucose transport is critical for systemic insulin sensitivity.

Muscle health is crucial for overall metabolic health. Impairing glucose uptake in muscle can negatively affect how your liver and fat tissue respond to insulin. Exercise and muscle maintenance support this glucose transport mechanism.

High-dose supplementation of fat-soluble vitamins (specifically Vitamin E and beta-carotene) and Vitamin A in well-nourished adults increases the risk of adverse health outcomes, including bleeding, cancer recurrence, and all-cause mortality, rather than providing preventive health benefits.

Do not assume high-dose fat-soluble vitamin supplements (A, E) are safe just because they are vitamins. In well-nourished adults, high doses (e.g., Vitamin E >800mg/day, Beta-carotene in smokers) are linked to increased risks of bleeding, cancer recurrence, and mortality. Stick to dietary sources or standard multivitamins unless a deficiency is diagnosed by a physician.

PPAR-γ agonists reduce inflammation in macrophages and vascular cells by inhibiting NF-κB and AP-1 signaling pathways, thereby slowing atherosclerosis progression.

By reducing inflammation in your blood vessels, certain diabetes medications (TZDs) may also help protect against heart disease and plaque buildup, offering benefits beyond just blood sugar control.

Genetic variants of the FOXO3 gene (specifically SNPs like rs2802292) are consistently associated with increased human longevity and reduced age-related mortality across diverse populations.

Your genetics play a significant role in how long you live, but they are not your destiny. Specific variants of the FOXO3 gene are linked to longevity, and this gene's activity can be influenced by your environment. You can support healthy aging by adopting lifestyle factors that activate FOXO3, such as caloric restriction and consuming phytochemicals like resveratrol and curcumin, which help regulate cellular stress and metabolism.

Rapamycin inhibits cell cycle arrest markers (p16, p21) and activates autophagy through an Nrf2-dependent mechanism.

To benefit from rapamycin's ability to stop cells from stopping dividing (cell cycle arrest), your body's Nrf2 antioxidant pathway must be functional.

Obesity alone does not cause insulin resistance or elevated cardiovascular disease risk; rather, insulin resistance is the primary driver of metabolic abnormalities and CVD risk, regardless of body weight.

Do not assume that being overweight automatically means you have dangerous metabolic issues or that your weight is the direct cause of your health problems. Instead, focus on improving insulin sensitivity through lifestyle changes. If you are overweight, you are more likely to be insulin resistant, but if you are not insulin resistant, your CVD risk may be lower than expected for your weight. Weight loss is effective for everyone regardless of insulin resistance, but it significantly improves metabolic markers (like triglycerides and inflammation) specifically in those who are insulin resistant.

Genetic deficiency of the circadian clock gene BMAL1 causes metabolic syndrome by impairing adipose tissue expansion, leading to elevated circulating fatty acids and subsequent ectopic fat accumulation in the liver and skeletal muscle.

This research highlights that metabolic health depends heavily on the capacity of adipose tissue to store fat. If fat cells cannot expand or function correctly (due to genetic or environmental factors), fat spills over into the liver and muscles, causing metabolic issues. Maintaining healthy adipose tissue function is crucial for preventing ectopic fat.

Chronic ingestion of a western diet (high glucose and free fatty acids) causes endothelial stress and platelet hyperactivity, which precedes and drives systemic metabolic inflammation and insulin resistance.

Focus on the quality and combination of your meals rather than just calorie counting or sugar avoidance. High-fat and high-carb meals can both trigger acute blood vessel stress. Prioritize whole foods that minimize rapid spikes in blood glucose and free fatty acids to protect your endothelial health and prevent the inflammation that leads to insulin resistance.

Pioglitazone (PPAR-gamma agonist) improves histological features of NASH but is limited by problematic weight gain and is not widely adopted.

Pioglitazone can improve liver histology in NASH patients (34% vs 19% placebo), but it causes weight gain and is not widely used. It is considered only when lifestyle changes fail and other options are not suitable.

Oral testosterone supplementation in elderly men with low-normal gonadal status leads to a significant decrease in High-Density Lipoprotein (HDL) cholesterol levels.

Older men considering testosterone therapy should be aware that it may lower HDL ('good') cholesterol. Regular monitoring of lipid profiles is recommended to manage this potential side effect, even though other lipid markers like LDL and triglycerides may remain unchanged.

Oral testosterone supplementation in elderly men with low-normal gonadal status leads to a significant increase in hematocrit levels.

Older men on testosterone therapy should have their hematocrit monitored regularly. An increase is expected, and if it becomes too high (above 50%), the dose may need to be reduced to prevent potential cardiovascular risks.

One night of total sleep deprivation increases resting blood pressure in healthy adults without increasing heart rate or muscle sympathetic nerve activity (MSNA).

Getting one night of zero sleep will likely raise your blood pressure the next morning, even if you don't feel stressed or your heart rate doesn't change. This suggests the mechanism isn't just 'stress nerves' firing, but potentially other vascular or hormonal factors. Prioritizing sleep is crucial for blood pressure management, not just for feeling rested.

Gastric bypass surgery (GBP) improves glucose metabolism and reduces obesity risk partly by altering gut microbiota composition and increasing the secretion of gut hormones (GLP-1, PYY), often before significant weight loss occurs.

Gastric bypass surgery reverses type 2 diabetes and improves metabolic health rapidly, often before significant weight loss. This is driven by anatomical changes that increase beneficial gut hormones (GLP-1, PYY) and alter gut bacteria. It is a highly effective intervention for severe obesity and diabetes.

In human skeletal muscle, obesity is associated with a specific defect in insulin receptor kinase activity toward exogenous substrates, which contributes to insulin resistance, whereas the structural integrity and autophosphorylation of the receptor remain normal.

In obesity, your muscle cells' ability to respond to insulin is impaired not just because there are fewer receptors, but because the receptors' internal signaling engine (kinase activity) is less effective at processing the signal. This is a biological adaptation to excess energy, not a permanent structural break. Addressing the underlying obesity is key to restoring this signaling efficiency.